Jeff E. Knight, Chief Development & Operating Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 85,163 shares at $40.10 ($3.4M) on 2026-04-08, disclosed to the SEC on 2026-04-10.
Scheduled sale ($3.4M) by Chief Development & Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CRNX | SELL | 2024-11-26 | $28K | — | Filing → |
| CRNX | SELL | 2024-07-17 | $1.5M | — | Filing → |
| CRNX | SELL | 2024-06-28 | $42K | — | Filing → |